Business Context and Reporting Period
InterPrivate Acquisition Corp. filed this Form 8-K on February 16, 2021, under Item 8.01 and Item 9.01(d). The filing announces that the SEC declared effective InterPrivate’s Form S-4 registration statement relating to its proposed business combination with Aeva, Inc. and that the definitive proxy statement/prospectus/consent solicitation statement had been filed and mailed.
The special meeting of InterPrivate stockholders is scheduled for March 11, 2021, at 11:00 a.m. Eastern time. The materials were mailed to stockholders of record as of January 25, 2021. The proposed transaction is governed by the Business Combination Agreement dated November 2, 2020, among Aeva, InterPrivate, and WLLY Merger Sub Corp.
Financial Metrics and Capitalization
This Form 8-K does not provide current-period revenue, profit, cash flow, margins, debt, liquidity, or operating performance metrics. The filing text does not provide a clear value for these items.
The filing references a minimum trust account amount following potential redemptions as a condition to closing, but does not state the applicable amount or expected post-redemption liquidity in this document.
Material Changes Versus the Prior Comparable Period
No period-over-period financial or operating comparison is presented. The material development is procedural: the registration statement became effective, the definitive transaction materials were filed, and mailing to stockholders commenced.
Guidance, Outlook, Risks, and Unusual Items
- Completion of the transaction remains subject to stockholder approvals, satisfaction of closing conditions, the minimum trust account requirement after redemptions, and certain governmental and regulatory approvals.
- The transaction may not close on a timely basis or at all, may require an extension of InterPrivate’s business-combination deadline, or may be terminated under the Business Combination Agreement.
- Identified business risks include Aeva’s ability to develop and commercialize its products, achieve or sustain profitability, obtain additional capital, manage growth, retain employees, protect intellectual property, and secure timely performance from suppliers and manufacturers.
- Additional risks include competition, regulatory and product-liability proceedings, legal proceedings related to the transaction, disruption to business relationships, securities-price volatility, changes in the combined capital structure, and failure to obtain or maintain a New York Stock Exchange listing.
- The filing contains forward-looking statements and cautions that actual results may differ materially. Neither company undertakes to update these statements.
- The filing is not itself a proxy solicitation or an offer to sell or buy securities. Investors are directed to the definitive proxy statement/prospectus/consent solicitation statement and other SEC filings.
Important Facts for Investors to Verify
- Review the definitive proxy statement/prospectus/consent solicitation statement for transaction terms, ownership, dilution, redemption mechanics, and pro forma financial information.
- Confirm the record date, March 11, 2021 special meeting date, and required stockholder approvals.
- Verify the minimum trust account condition and the potential effect of public-stockholder redemptions on transaction funding and liquidity.
- Review Aeva’s historical financial statements, projected financial information, cash requirements, and assumptions regarding future profitability.
- Review the full risk factors in the registration statement, proxy materials, and InterPrivate’s other SEC filings, including risks concerning transaction completion and NYSE listing.